Human immunodeficiency virus (HIV) / Acquired immune deficiency syndrome (AIDS)
- Business planning toolkit in HIV
- Development of a payer value story in HIV
- Payer value story briefing document in HIV
- Review of an economic model for HIV and submission to the SMC
- Budget impact model in HIV
- Targeted literature review of adherence in HIV
- Targeted literature review in HIV and inflammation
- Targeted literature synthesis of viral blips and viremia in patients with HIV
- Literature review on inflammation in patients with HIV
- Consulting in a multinational case-control study: Impact of side effects on the quality of life (QoL) of HIV patients
- Advisory board consultation regarding product status and development in HIV
- General consultancy on PRO endpoints in HIV/AIDS trials
- Recommendations for the inclusion of PROs into HIV trials
- Development of an expert report and FDA meeting on tolerability in HIV
- Consulting on the development of a PRO strategy for international HIV trials with interviews in the US and Puerto Rico
- Consulting on study documents and development of SAP for psychometric validation of a PRO instrument of tolerability in patients with HIV
- Preparation and development of a manuscript on HIV Patient Symptom Profile (HIV PSP)
- Preliminary psychometric validation of the HIV PSP questionnaire using the UK SWITCH study data
- Analysis of HIV PSP data from the SWITCH study to compare treatment arms
- Confirming concept definitions of the HIV Treatment Tolerability Index for translation purposes
- An evidence synthesis on the efficacy and safety of two drugs and protease inhibitors in treatment‑naïve HIV patients
- Manuscript network meta-analysis of an antiretroviral drug for the treatment of HIV
- Budget impact tool for an antiretroviral drug for treatment-naive HIV
- Literature review of the epidemiology and burden of illness in HIV-related neuropathy
- Top-up literature review, revised manuscript and presentations on HIV and AIDS
- Development and psychometric validation of a PRO instrument of tolerability in patients with HIV
- Two abstracts, two posters and a manuscript on the development and psychometric validation of a PRO instrument of tolerability in patients with HIV
- Selection of PRO measures for HIV trials